Genflow Biosciences PLC (LSE:GENF) CEO Dr Eric Leire spoke to Proactive about an injection of funding from long-standing Estonian partner IVEX. The funding will allow Genflow to run an additional research programme without eating into any of its existing capital, he said.
Dr Leire also spoke about some "extremely promising" data and the company's first-half results.